期刊文献+

卵黄抗体对幽门螺杆菌感染沙土鼠的预防试验 被引量:1

Inhibitory Effect of Egg-yolk Antibody on Experimental Helicobacter Pylori Infection in Mongolian Gerbils
下载PDF
导出
摘要 目的在成功研制出抗幽门螺杆菌(Hp)卵黄抗体的基础上,利用蒙古沙土鼠作为实验动物,观察抗Hp卵黄抗体对Hp感染的防治作用。方法将144只实验鼠随机分为4组,每组36只。Ⅰ、Ⅱ、Ⅲ组分别灌服生理盐水、复合抗生素和抗Hp卵黄抗体,1次/d,连续13 d;Ⅳ组皮下注射抗Hp卵黄抗体,1次/d,48 h后再注射1次。在首次用药后48 h口服接种幽门螺杆菌(ATCC43504)2.75×108CFU(布氏培养液)。结果在接种后第15、30、45天,Ⅰ组鼠胃内均有大量Hp定植,感染率为100%;Ⅱ、Ⅲ、Ⅳ组的感染率均<23%,3组之间的差异无统计学意义(P<0.05)。结论灌服和注射抗Hp卵黄抗体,可以抑制沙土鼠感染Hp,其抑制效果与抗生素相仿。 Objective Inhibitory effect of egg-yolk antibody on experimental Helicobacter pylori (Hp) infection in Mongolian gerbil was observed as soon as egg-yolk antibody against Hp was prepared. Method The experiment gerbils were divided into 4 groups(36 mice/group) and then normal saline was taken orally normal saline in group Ⅰ , combination of antibiotics in Group Ⅱ, egg-yolk antibody against Hp in Group Ⅲ for 13 days (one time/d). The egg-yolk antibody was injected hypodermically twice with a 48 h interval in group Ⅳ. 48 h after first time administration the mice were inoculated with 2.75×10^8 colony formation units(CFUs) of Hp(ATCC43504) bacteria grown in Brucella broth. Results There were more Hp in the stomach on the 7th,15th,30th,45th day after inoculation. The infection rate was 100% in group Ⅰ , but low than 23% in Group Ⅱ, Group Ⅲ or group Ⅳ. Conclusion The egg-yolk antibody against Hp swallowed or injected might decrease HP infection in the stomach of Mongolian gerbils, and there is no obvious difference in effect between the egg-yolk antibody and the antibiotic(P〈0.05).
出处 《苏州大学学报(医学版)》 CAS 北大核心 2007年第5期715-717,732,共4页 Suzhou University Journal of Medical Science
基金 江苏泰州市科技局科技攻关项目(NO.TL200519)
关键词 幽门螺杆菌 卵黄抗体 蒙古沙土鼠 Helicobacter pylori egg-yolk antibody Mongolian gerbil
  • 相关文献

参考文献8

二级参考文献20

  • 1谢献胜,王峰,周新民,刘俊栋,卢炜,周冬仁.抗幽门螺旋杆菌卵黄抗体的制备及其体外抑菌试验[J].中国家禽,2005,27(13):12-14. 被引量:6
  • 2萨姆布鲁克J 弗里奇EF 曼尼阿蒂斯T 金冬雁 黎孟枫 侯云德等译.分子克隆实验指南[M].北京:科学出版社,1992..
  • 3Qdaka T, Yamaguchi T, Koyama H, et al. Evaluation of the Helieobacter pylori stool antigen test for monitoring eradication therapy. Am J Gastroenterol, 2000, 97:594-599
  • 4El-zimanty HM, Graham DY. Evaluation of gastric mucosal biopsy site and number for identification of Helieobacter pylon or intestinal metaplasia: role of the Sydney System. Hum Pathol, 1999,30:72-77
  • 5徐采朴.14C-UBT在幽门螺杆菌感染中的作用[A]..中华医学会第二届全国幽门螺杆菌专题会议论文汇编[C].,1987.63.
  • 6Burget DW, Chiverton SG, Hunt RH, et al. Is there an optimal degree of acid suppression for healing of duodenal ulcer [J]. Gastroenterology, 1999; 99: 345.
  • 7Mojica Narat.Production of Antibodies in Chickens[J].Food Technol Biotechnol,2003,41 (3):259-267.
  • 8Lee EN,Sounwoo HH,Menninen K,et al.In vitro studies of chicken egg yolk antibody (IgY) against Salmonella enteritidisand Salminella typhimurium[J].Pot Sci,2002,81(5):632.
  • 9杨廷彬,尹学念.实用免疫学[M]长春:长春出版社,1992:365.
  • 10Ebina T,Sato A,Umezu K,et al.Prevention of rotavirus infection by oral administration of cow colostrum containing antihuman rotavirus antibody[J].Med Microbiol Immunol,1985,174:177.

共引文献11

同被引文献11

  • 1张强英,余咏文,黄惠清,李鸣.儿童幽门螺杆菌感染与白细胞介素-8含量的关系[J].中国当代儿科杂志,2004,6(4):284-286. 被引量:4
  • 2张绍兰,杨致邦,毛小琴.抗幽门螺杆菌粘附素HpaA卵黄抗体的制备[J].中国人兽共患病学报,2006,22(3):265-267. 被引量:6
  • 3周慊.三联疗法治疗幽门螺旋杆菌相关性胃溃疡的疗效观察[J].医学临床研究,2006,23(2):265-266. 被引量:3
  • 4Aslan S, Yilmaz I, Bal N, et al. Investigation of ttelicobacter pylori in tonsiltary tissue with pronto dry test and pathologic examination [J]. Aurls Nasus Larynx, 2007, 31(3): 339-342.
  • 5Serrano C, Diaz M I, Valdivia A, et al. Relationship between Helicobacter pylori virulence factors and regulatory eytokines as predictors of clinical outcome [J]. Microbes and Infection, 2007, 9(4): :428-434.
  • 6Wolle K, Malfertheine P. Treatment of Helicobacter pylori [J]. Best Practice and Research Clinical Gastroenterology, 2007, 21(2) : 315-324.
  • 7Gulhan M, Canbakan S, Ahmed K, et al. Helicobacter pylori in bronchiectasis: a polymerase chain reaction assay in bronchoalveolar lavage fluid and bronchiectatic lung tissue [J]. Archives of Medical Research, 2007, 38(3): 317- 321.
  • 8Ishak R A H, Awad G A S, Mortada N D, et al. Preparation, in vitro and vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy [J]. Journal of Controlled Release, 2007, 119(2): 207-214.
  • 9Rajinikanth P S, Balasubramaniam J, Mishra B. Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori [J]. International Journal of Pharmaceutics, 2007, 335(1/2) : 114-122.
  • 10程慧敏,张人立,王鹏程,王旭波,崔涛,王颖,沈桂清,唐采白.幽门螺杆菌相关性胃炎和幽门螺杆菌非相关性胃炎中淋巴滤泡的意义[J].徐州医学院学报,1997,17(4):374-377. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部